Member Info for TGoodland

Raab just said scaled-testing is going to be a key component over the medium to long term.

Haha should have known that was ruffle a few feathers. Sorry guys haven’t had my morning coffee.

I think Avct is a fantastic company with potential but I’m frustrated reading the RNS as they are mostly waffle.

Management are just flying news out to the market when they should be more measured and send out actual Rns that are going to help develop revenue and EPS

Haha this company just updates the market on potential potential potential. - When is the results/revenue going to start?

Company has just had a placing and needs to find a way to fund all these new long shot projects.

Some of the RNS’s just make a loose misleading reference to AZN & GSK. - ‘GSK invested 250m etc...’ it’s nothing to do with Avct.

Sounds like they’ll use the Roche ones for now but why would they use a more expensive external test as opposed to the govt consortium.

It’ll be cheaper and better PR that the government have made a test rather than using a Swiss company.

To Chartwell for giving us an extra 2m tests per month.

Lovely stuff. Sales figs will come along in due course, sit tight and be patient :)

I'd like to know where the Testing sites are.... Hoepfully UK, France and US.

Are we approved in Brazil?

Nice one GLR - This board needs more informative discussion rather than accusing everyone of Ramping/Deramping every post.

I hope you're right, NCYT is my biggest position in my portfolio and i am concerned around the lack of Market Share in the US but the Global Market is definitely still big enough without the US.

Would be nice to see the French pull their finger out as us part of their 700k a week once we have the new test up and running.

Yeah over 80 countries, but we have 0 clarity on how much they've been buying.

Could be 1 96x Test each for all we know.

Hopefully the results this week can provide some good clarity on Margins and therefore EPS.

Sounds like we've been excluded in the US as we're not one of the names Trump said, being stonewalled by the French Govt & only winning UK contracts due to the AZN/GSK tie up.

So frustrating

Telegraph article says that Mologic CEO Dr Fitchett isnt going to profit from the Virus (meaning overseas countries i think?)

https://www.telegraph.co.uk/global-health/science-and-disease/makers-home-antibody-test-seek-urgent-nhs-approval/

Any views? We're not quoted either...

The dips because they have missed the original 10th May deadline for FDA approval. In the CEO's latest comments he said he expects it before H2 so not utterly surprising that deadline's been missed.

I'm Still very bullish on the company but would be great to get Belluscura to the market ASAP with Salarius already there.

The market is going to beat the stock down a bit as it's purely driven by Covid news at the moment which is ridiculous as i think Salarius will be a bigger product than our COPD machine.

Was meant to be a thumbs up not question marks !!

Thanks Sharedealer????

Labs next week? Why are they not live already? Is this potentially due to the bottleneck they mentioned?

the ‘new’ technology without reagents goes live next week so maybe that’s why sales were only £90m. Once the labs are open the revenues will fly

Any expected timeline on the FDA ruling?